Company Overview
AKI India Limited, together with its subsidiary, AKI UK Limited, manufactures and trades leather and leather goods in India and internationally. The company offers leather accessories, including belts for men and women, duffel and small tote bags, as well as large briefcases and men's backpacks; and leather wallets and card holders. It also provides leather shoes comprising formal, riding, deck, casual, and canvas shoes, as well as countryside boots; and pet accessories consisting of dog toys, collars, and leads. In addition, the company offers finished leather products, such as bag, upholstery, footwear, and belt leather, as well as washable nubucks; and equestrian products comprising horse covers, bridles, rugs, stirrup leather, halters, girths, nosebands, and harness sets. Further, it distributes leather chemicals. The company also exports its products. The company was formerly known as AKI India Private Limited and changed its name to AKI India Limited. AKI India Limited was incorporated in 1994 and is based in Kanpur, India.
Why Investors Should Care
Net profit has compounded at 18.7% per year over the last five years.
Revenue has grown at a 15.2% CAGR over the past five years.
Trades at a P/E of 24.7, below the sector median of 30.4.
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Mar 2026 Revenue of ₹107.33 Cr (+32.6% YoY); net profit ₹1.93 Cr.
- Trailing 12 Months Year-on-year growth — revenue +32.6%, earnings +15.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.2%, profit CAGR 18.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.17% |
| 1 Year: | 32.57% |
Compounded Profit Growth
| 5 Years: | 18.74% |
| 1 Year: | 15.29% |
Stock Price Performance
| 1 Year: | -69.58% |
| 6 Months: | -24.48% |
| 3 Months: | -9.81% |
| 1 Month: | -4.87% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.70 · Neutral
P/E of 24.68 is below the sector median of 30.43 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 15.2% over 5 years.
- Profit CAGR of 18.7% over 5 years.
CONS
- Trading 69.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AKI AKI India Limited NSE | 4.69 | 24.68 | ₹48.40 Cr | 0.00% | 4.60% | 1.93% | 15.17% | 18.74% |
| 2 | MARUTI Maruti Suzuki India Limited NIFTY50NSEAI | 13,542.00 | 29.36 | ₹4.26 L Cr | 1.01% | 17.22% | 13.70% | 16.60% | 21.11% |
| 3 | TITAN Titan Company Limited NIFTY50NSE | 4,602.10 | 80.47 | ₹4.09 L Cr | 0.33% | 38.43% | 32.31% | 29.24% | 16.00% |
| 4 | M&M Mahindra & Mahindra Limited NIFTY50NSEAI | 3,108.80 | 20.43 | ₹3.87 L Cr | 1.05% | 17.14% | 18.37% | 17.50% | 18.48% |
| 5 | BAJAJ-AUTO Bajaj Auto Limited NIFTY50NSE | 10,348.50 | 26.92 | ₹2.89 L Cr | 1.48% | 26.12% | 27.67% | 19.49% | 21.03% |
| 6 | ETERNAL Eternal Limited NSEAITECH | 290.35 | 744.49 | ₹2.80 L Cr | 0.00% | 2.87% | 1.18% | 97.70% | 45.90% |
| 7 | EICHERMOT Eicher Motors Limited NIFTY50NSEAI | 7,354.50 | 42.67 | ₹2.02 L Cr | 1.11% | 26.43% | 21.97% | 17.47% | 23.70% |
| 8 | TVSMOTOR TVS Motor Company Limited NSE | 3,644.70 | 57.37 | ₹1.73 L Cr | 0.33% | 28.82% | 31.56% | 20.21% | 31.46% |
| 9 | HYUNDAI HYUNDAI MOTOR INDIA LTD NSE | 2,035.00 | 30.44 | ₹1.65 L Cr | 1.06% | 32.62% | 27.14% | 5.50% | 4.87% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.52 Cr | 14.40 Cr | 17.12 Cr | 19.28 Cr | 20.12 Cr | 20.77 Cr | 13.56 Cr | - | 24.02 Cr | 17.66 Cr | 27.52 Cr | 25.56 Cr | 36.58 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 19.88 Cr | 12.51 Cr | 22.15 Cr | 22.28 Cr | 32.18 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 4.14 Cr | 5.15 Cr | 5.37 Cr | 3.29 Cr | 4.40 Cr |
| Operating Expenses | 13.66 Cr | 13.73 Cr | 16.50 Cr | 18.86 Cr | 19.48 Cr | 20.27 Cr | 13.93 Cr | - | 5.46 Cr | 6.27 Cr | 5.41 Cr | 5.51 Cr | 6.35 Cr |
| Operating Income | 38.00 L | 27.00 L | 15.00 L | -5.00 L | 13.00 L | 6.00 L | -80.00 L | - | -1.32 Cr | -1.12 Cr | -3.96 L | -2.23 Cr | -1.95 Cr |
| EBITDA | 86.00 L | 67.00 L | 62.00 L | 42.00 L | 64.00 L | 50.00 L | -37.00 L | - | 1.57 Cr | 1.31 Cr | 1.86 Cr | 2.23 Cr | 2.23 Cr |
| Interest Expense | 67.00 L | 53.00 L | 44.00 L | 50.00 L | 36.00 L | 39.00 L | 40.00 L | - | 63.20 L | 51.97 L | 55.63 L | 49.53 L | 54.34 L |
| Pretax Income | 21.00 L | 47.00 L | 31.00 L | 39.00 L | 72.00 L | 62.00 L | 55.00 L | - | 44.02 L | 33.34 L | 80.71 L | 1.21 Cr | 1.13 Cr |
| Tax Provision | -2.00 L | 15.00 L | -14.00 L | 14.00 L | 14.00 L | 19.00 L | 16.00 L | - | 30.66 L | 10.30 L | 18.87 L | 11.51 L | 37.00 L |
| Net Income | 23.00 L | 32.00 L | 45.00 L | 25.00 L | 57.00 L | 43.00 L | 39.00 L | - | 13.36 L | 20.77 L | 77.37 L | 2.45 Cr | 76.45 L |
| Diluted EPS | 0.03 | 0.05 | 0.07 | 0.04 | 0.07 | 0.05 | 0.04 | - | 0.02 | 0.02 | 0.06 | 0.11 | 0.07 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.00 Cr | 33.00 Cr | 40.00 Cr | 41.00 Cr | 46.00 Cr | - | 70.26 Cr | 69.55 Cr | 80.96 Cr | 107.33 Cr |
| Cost of Revenue | - | - | - | - | - | - | 59.01 Cr | 59.88 Cr | 65.51 Cr | 89.12 Cr |
| Gross Profit | - | - | - | - | - | - | 11.26 Cr | 9.67 Cr | 15.45 Cr | 18.21 Cr |
| Operating Expenses | 14.00 Cr | 33.00 Cr | 39.00 Cr | 40.00 Cr | 45.00 Cr | - | 9.93 Cr | 8.69 Cr | 17.42 Cr | 24.36 Cr |
| Operating Income | -0 | -1.00 Cr | 0 | 0 | 0 | - | 1.32 Cr | 97.75 L | -1.96 Cr | -6.16 Cr |
| EBITDA | -0 | 0 | 1.00 Cr | 1.00 Cr | 1.00 Cr | - | 5.06 Cr | 5.39 Cr | 6.37 Cr | 6.85 Cr |
| Interest Expense | 0 | 2.00 Cr | 2.00 Cr | 2.00 Cr | 1.00 Cr | - | 1.59 Cr | 1.66 Cr | 1.89 Cr | 2.11 Cr |
| Pretax Income | 0 | -1.00 Cr | 0 | 0 | 2.00 Cr | - | 1.57 Cr | 1.88 Cr | 2.67 Cr | 2.71 Cr |
| Tax Provision | 0 | 7.00 L | -0 | 0 | 62.00 L | - | 41.50 L | 51.05 L | 98.90 L | 77.68 L |
| Net Income | 0 | -1.00 Cr | 0 | 0 | 1.00 Cr | - | 1.16 Cr | 1.37 Cr | 1.68 Cr | 1.93 Cr |
| Diluted EPS | 0.18 | -1.10 | 0.17 | 0.03 | 0.23 | - | 0.15 | 0.16 | 0.19 | 0.19 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 16.00 Cr | 38.00 Cr | 40.00 Cr | 40.00 Cr | 37.00 Cr | - | 63.25 Cr | 104.11 Cr | 114.37 Cr | 160.14 Cr |
| Current Assets | - | - | - | - | - | - | 45.48 Cr | 70.44 Cr | 81.13 Cr | 124.05 Cr |
| Cash & Equivalents | - | - | - | - | - | - | 1.47 Cr | 1.81 Cr | 2.78 Cr | 4.69 Cr |
| Inventory | - | - | - | - | - | - | 19.63 Cr | 27.34 Cr | 30.43 Cr | 51.38 Cr |
| Receivables | - | - | - | - | - | - | 19.88 Cr | 21.09 Cr | 28.59 Cr | 31.00 Cr |
| Total Liabilities | - | - | - | - | - | - | 48.27 Cr | 44.40 Cr | 49.23 Cr | 59.82 Cr |
| Current Liabilities | - | - | - | - | - | - | 38.14 Cr | 43.31 Cr | 45.92 Cr | 55.40 Cr |
| Long Term Debt | - | - | - | - | - | - | 10.12 Cr | 1.09 Cr | 3.31 Cr | 4.43 Cr |
| Total Debt | 8.00 Cr | 21.00 Cr | 22.00 Cr | 21.00 Cr | 16.00 Cr | - | 29.51 Cr | 21.84 Cr | 22.42 Cr | 21.45 Cr |
| Total Equity | 2.87 Cr | 3.00 Cr | 3.00 Cr | 6.00 Cr | 8.00 Cr | - | 14.99 Cr | 59.71 Cr | 65.14 Cr | 100.32 Cr |
| Shares Outstanding | - | - | - | - | - | - | 6.69 Cr | 8.58 Cr | 8.85 Cr | 10.32 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | 1.00 Cr | -1.00 Cr | 3.00 Cr | - | -1.05 Cr | -17.62 Cr | -2.67 Cr | -15.91 Cr |
| Investing Cash Flow | - | - | -3.00 Cr | -1.00 Cr | 1.00 Cr | - | -73.92 L | -17.69 Cr | -1.51 Cr | -4.89 Cr |
| Financing Cash Flow | - | - | 1.00 Cr | 1.00 Cr | -4.00 Cr | - | 1.99 Cr | 35.65 Cr | 5.15 Cr | 22.71 Cr |
| Capital Expenditure | - | - | -2.00 Cr | -1.00 Cr | -1.00 Cr | - | -2.28 Cr | -4.96 Cr | -2.48 Cr | -5.09 Cr |
| Free Cash Flow | - | - | -1.00 Cr | -2.00 Cr | 2.00 Cr | - | -3.33 Cr | -22.58 Cr | -5.15 Cr | -21.00 Cr |
| Net Change in Cash | - | - | -0 | -0 | -0 | - | 20.27 L | 34.02 L | 96.81 L | 1.91 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | 16.0% | 13.9% | 19.1% | 17.0% |
| Operating Margin % | -0.0% | -3.0% | 0.0% | 0.0% | 0.0% | - | 1.9% | 1.4% | -2.4% | -5.7% |
| Net Margin % | 0.0% | -3.0% | 0.0% | 0.0% | 2.2% | - | 1.6% | 2.0% | 2.1% | 1.8% |
| ROE % | 0.0% | -33.3% | 0.0% | 0.0% | 12.5% | - | 7.7% | 2.3% | 2.6% | 1.9% |
| ROCE % | - | - | - | - | - | - | 5.3% | 1.6% | -2.9% | -5.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AKI
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Clinical Trials Arena
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNM0hxT21Xb3Qzdk51N0x3TjRBemxRUjlyMFVuQ20tY3FfVkJOR29RUlhLdUFnTmlzY2tXVWpZYXRLcDQtcllldkdxajRCX1VZVThuNWNHeGFsdkE2bUFwSTBfWjBNS0hobkpZbHFtT0xoZ0FTRlEtZU1jS0RvYUJYWGlKUEItbDEtNUhkaz…
New trial targets kidney injury after heart surgery in $1B market - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNM0ROclRBT3hvb3IydDZoYTlRd0FqRGRmUU9RVmFuRXpsbVhLa2o0NlB6dkwxbFl3Ukk1cE02djk4Q21waFZUMmJMOHJhbm14dkRERlk5SnY4N0h1Q1hMY05Hc2Vjd2VCOXlYVUFZcWdlR2duRjNsUVczUG5XZHF4dEstOXhqSmk3QU1wOG…
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PR Newswire
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNNE9wOFZXMW1hQVlGRGFyaU5tT1pTRWRhY3ZzcExYVUNJNmNpSmV6Y1hfZHIzcGpScVg3M24wYk9YLUV4VjY0dEduaFREQV82ako1a25lM2hrMkdLVklWc3liaE1JNzlpdldCUjJqN01id3BTWDREWDB6UzBXWEk2d0VVTGFFRmZRUEJoZ3…
CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern' - Fierce Biotech
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOV3lRV3A2TjNkTTJKdHhTYVljYkswYWdQUy1JUW1XQl9ISTg2LWo2V3piZ0hSazVyNE5YSDVxZVBRalJWbTFwZFpjV0xNTk9vQ3pjVVVYWVJka1V3Z2FVMmdIc0VCeTA5Wnh3dlpFalNWNzd5RjRodEdwLVpoN1N3dlhxdXhrelhaRll3SX…
EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxNcmo4Y0U4dEV1MlVLZkdxcFNGdFRmczJYY2hZV285dVhKNS1Fdy1VV216bWU0LWZLV2lVOXV1Y2NqOHNyOVV3cnJ3MER5a3pJeDJfaW5BcUk1NU5ITTU2TWxjclJKY3lkY3NSTWt3eVpjdGIzVlVQQkJBaTJZVnMwa0ZTcHZJTVhZS19NVn…
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxNSzdUS0V4YmJGaVcxQjF3QmFKSmRmWmRkM204UkctbVc4YVNaeVBKMmc2WFI4RE9UZWJQV3pXM3g2bHRsRkxqVmtjalRrdzNzMHhfT2RBQy10NURNdFlaNkJEWUN2U2p4djNkRERnYzM1V1FNbGhwYVVQNkhYMXEtaHdPSkxDa1N4eFFHbD…
AKI — Frequently Asked Questions
What is the current share price of AKI India Limited (AKI)?
As of 2026-07-15 09:52 IST, AKI India Limited (AKI) trades at ₹4.69 on NSE. Its 52-week range is ₹3.92 to ₹15.52.
What is the market capitalisation of AKI?
AKI India Limited (AKI) has a market capitalisation of ₹48.40 Cr on NSE.
What is the P/E ratio of AKI?
AKI trades at a trailing price-to-earnings (P/E) ratio of 24.68. The industry average P/E is 30.43. Its price-to-book (P/B) ratio is 0.61.
What is the return on equity (ROE) of AKI?
AKI has a return on equity (ROE) of 1.93%. Its return on capital employed (ROCE) is 4.60%.
Is AKI a good stock to buy?
This page provides a data-driven analysis of AKI India Limited (AKI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.